Discover how the first FDA De Novo-granted PCR assay can help your healthcare facility prevent Candida auris outbreaks and protect vulnerable patients. Simplexa^® C. auris Direct delivers rapid, accurate results with a streamlined workflow—no DNA extraction required—enabling effective infection control with excellent clinical performance. Fill out the form below to request more information and learn how this innovative solution can support your infection prevention strategy.

Interested to hear from us about the Simplexa^® C. auris Direct?

Fill out the form below to request more information from a sales representative and learn how this innovative solution can support your infection prevention strategy.